BioCentury
ARTICLE | Company News

CIBA files Rescula for U.S. and EU approval

March 3, 2000 8:00 AM UTC

CIBA Vision completed marketing filings in the U.S. and EU for Rescula unoprostone isopropyl ophthalmic solution to treat glaucoma. CIBA licensed Rescula from Ueno Fine Chemicals (Tokyo, Japan). ...